Clinical trial
Brain Injury and Ketamine: a Prospective, Randomized Controlled Double Blind Clinical Trial to Study the Effects of Ketamine on Sedative Sparing and Intracranial Pressure in Traumatic Brain Injury Patients.
NCT05097261 is registered in ClinicalTrials.gov with Geert Meyfroidt, MD, PhD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Brain Injury and Ketamine: a Prospective, Randomized Controlled Double Blind Clinical Trial to Study the Effects of Ketamine on Sedative Sparing and Intracranial Pressure in Traumatic Brain Injury Patients.
- Lead sponsor
- Geert Meyfroidt, MD, PhD
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- September 6, 2021
- Completion date
- June 30, 2026
- Enrollment
- 100 (estimated)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.